Back to Business

Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock

Business April 23, 2026 at 10:55 PM

Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock

Investing.com

Read at Investing.com

More Stories

X-energy prices IPO at $23 per share, to begin trading today

X-energy prices IPO at $23 per share, to begin trading today

🇺🇸 Investing.com 45m ago

Earnings call transcript: Pilbara Minerals Q3 2026 sees record results and strategic expansion

Earnings call transcript: Pilbara Minerals Q3 2026 sees record results and strategic expansion

🇺🇸 Investing.com 47m ago

SBC Medical Group Holdings chairman & CEO sells $9.37m in stock

SBC Medical Group Holdings chairman & CEO sells $9.37m in stock

🇺🇸 Investing.com 50m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play